eIF3c: A potential therapeutic target for cancer
- 25 April 2013
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 336 (1), 158-166
- https://doi.org/10.1016/j.canlet.2013.04.026
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Functional Characterization of the Role of the N-terminal Domain of the c/Nip1 Subunit of Eukaryotic Initiation Factor 3 (eIF3) in AUG RecognitionPublished by Elsevier BV ,2012
- Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3)Proceedings of the National Academy of Sciences of the United States of America, 2011
- Hyaluronan–CD44 interactions as potential targets for cancer therapyThe FEBS Journal, 2011
- The C-Terminal Region of Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes mRNA Recruitment, Scanning, and, Together with eIF3j and the eIF3b RNA Recognition Motif, Selection of AUG Start CodonsMolecular and Cellular Biology, 2010
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological TargetsCell, 2009
- Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3Proceedings of the National Academy of Sciences of the United States of America, 2008
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory TargetScience, 2008
- Reconstitution reveals the functional core of mammalian eIF3The EMBO Journal, 2007
- Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c)Human Molecular Genetics, 2006
- Alternative mechanisms of initiating translation of mammalian mRNAsBiochemical Society Transactions, 2005